Lupin and its subsidiary, Lupin Pharmaceuticals, Inc have settled all ongoing litigation over Solodyn (minocycline HCI, USP) extended release tablets with Medicis Pharmaceutical Corporation.
The settlement entitles Lupin to sell its generic versions of Solodyn in 45mg, 90mg, and 135mg strengths under a license from Medicis commencing November 2011 or earlier under certain conditions. The settlement also entitles Lupin to sell its generic versions of Solodyn in 65mg and 115mg strengths under a license from Medicis effective in February 2018 or earlier under certain conditions.
In addition, the settlement entitles Lupin to sell its generic versions of Solodyn in 55mg, 80mg and 105mg strengths under a license from Medicis effective in February 2019 or earlier under certain conditions.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1463.55 |
Dr. Reddys Lab | 5791.00 |
Cipla | 1448.80 |
Zydus Lifesciences | 1031.75 |
Lupin | 1580.20 |
View more.. |